Ultra-low dose dry powder inhaler technology for the treatment of respiratory diseases

超低剂量干粉吸入技术治疗呼吸系统疾病

• 批准号: LP120200744
• 负责人: Prof Paul Young
• 金额: $ 24.72万
• 依托单位: The University of Sydney
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-06-03 至 2015-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP120200744
• 关键词: Ultra; low; dose; dry; powder

Drug molecules are being developed for respiratory diseases, which are highly potent but beyond our capability in terms of delivery. Using a combination of high-end particle engineering and characterisation approaches, coupled with computational modelling, the project will develop a theoretical model that can be used to deliver ultra-low doses to the lungs.

目前正在开发治疗呼吸道疾病的药物分子，这些药物非常有效，但在输送方面超出了我们的能力。通过结合高端粒子工程和表征方法，再加上计算建模，该项目将开发一个可用于向肺部提供超低剂量的理论模型。